Multilevel regulation of NF-kappa B signaling by NSD2 suppresses Kras-driven pancreatic tumorigenesis
W. Feng, N. Niu, P. Lu, H. Rao, Z. Chen, W. Zhang, C. Ma, C. Liu, Y. Xu, W.-Q. Gao, J. Xue, L. Li
This study shows NSD2 acts as a tumor suppressor in Kras-driven pancreatic cancer by regulating NF-kappa B signaling through multiple mechanisms.
bioRxiv · Sep 11, 2023 · PreprintCancer Biology